Literature DB >> 10993496

Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.

L Vanopdenbosch1, B Dubois, M B D'Hooghe, F Meire, H Carton.   

Abstract

Multiple sclerosis (MS) and Leber's hereditary optic neuropathy (LHON) have been found to occur in combination. Based on an extensive literature search and on a clinical analysis of 55 LHON pedigrees (103 patients) and 40 patients with definite MS, this study concludes that the association of LHON and MS is more than a coincidence, and that carrying a primary LHON mutation is a risk factor for developing MS. All three primary LHON mutations occurring in the European and North American populations have been found to be associated with an MS-like syndrome. The neurological characteristics of MS associated with LHON are indistinguishable from those of MS in general, but the severe and bilateral visual symptoms and signs justify considering these patients as a clinical subgroup of MS and screening them for LHON mutations. However, screening LHON patients for MS appears to be more rewarding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993496     DOI: 10.1007/s004150070153

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  Spastic paraparesis as a manifestation of Leber's disease.

Authors:  Frédéric Clarençon; Emmanuel Touzé; Anne Leroy-Willig; Hélène Turmel; Olivier Naggara; Stéphane Pavy; Antoine Brézin; Jean-Louis Mas
Journal:  J Neurol       Date:  2005-11-23       Impact factor: 4.849

2.  Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination.

Authors:  S Venkateswaran; K Zheng; M Sacchetti; D Gagne; D L Arnold; A D Sadovnick; S W Scherer; B Banwell; A Bar-Or; D K Simon
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

3.  Mitochondrial mutation in Iranian patients with multiple sclerosis, correlation between haplogroups H, A and clinical manifestations.

Authors:  Mojdeh Ghabaee; Motahar Omranisikaroudi; Shahla Amrisaroukolaei; Alipasha Meysamie; Mohammad Ali Sahraian; Asghar Bayati; Mohammad Hossein Sanati; Mossoud Houshman; Homa Sadeghian; Khalili Vajihazaman
Journal:  Cell Mol Neurobiol       Date:  2008-11-14       Impact factor: 5.046

4.  Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.

Authors:  M Bonora; E De Marchi; S Patergnani; J M Suski; F Celsi; A Bononi; C Giorgi; S Marchi; A Rimessi; J Duszyński; T Pozzan; M R Wieckowski; P Pinton
Journal:  Cell Death Differ       Date:  2014-03-21       Impact factor: 15.828

Review 5.  Mitochondrial dysfunction in alveolar and white matter developmental failure in premature infants.

Authors:  Vadim S Ten
Journal:  Pediatr Res       Date:  2016-11-03       Impact factor: 3.756

Review 6.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 7.  Will the real multiple sclerosis please stand up?

Authors:  Peter K Stys; Gerald W Zamponi; Jan van Minnen; Jeroen J G Geurts
Journal:  Nat Rev Neurosci       Date:  2012-06-20       Impact factor: 34.870

8.  Late-onset progressive visual loss in a man with unusual MRI findings: MS, Harding's, Leber's or Leber's Plus?

Authors:  N Cawley; A Molloy; L Cassidy; N Tubridy
Journal:  Ir J Med Sci       Date:  2010-10-01       Impact factor: 1.568

9.  Oligodendroglial differentiation induces mitochondrial genes and inhibition of mitochondrial function represses oligodendroglial differentiation.

Authors:  Robert Schoenfeld; Alice Wong; Jillian Silva; Ming Li; Aki Itoh; Makoto Horiuchi; Takayuki Itoh; David Pleasure; Gino Cortopassi
Journal:  Mitochondrion       Date:  2009-12-22       Impact factor: 4.160

Review 10.  Adult-onset leukodystrophies from respiratory chain disorders: do they exist?

Authors:  Ettore Salsano; Laura Farina; Costanza Lamperti; Giuseppe Piscosquito; Franco Salerno; Lucia Morandi; Franco Carrara; Eleonora Lamantea; Massimo Zeviani; Graziella Uziel; Mario Savoiardo; Davide Pareyson
Journal:  J Neurol       Date:  2013-01-29       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.